These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35313785)

  • 21. [Progress in epidemiological research of 2019-nCoV infection and COVID-19 vaccination in pregnancy].
    Yang JT; Liu ZK; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Aug; 43(8):1215-1221. PubMed ID: 35981982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.
    Juncker HG; Mulleners SJ; van Gils MJ; de Groot CJM; Pajkrt D; Korosi A; van Goudoever JB; van Keulen BJ
    J Hum Lact; 2021 Aug; 37(3):477-484. PubMed ID: 34176363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study.
    Selma-Royo M; Bäuerl C; Mena-Tudela D; Aguilar-Camprubí L; Pérez-Cano FJ; Parra-Llorca A; Lerin C; Martínez-Costa C; Collado MC
    Genome Med; 2022 Apr; 14(1):42. PubMed ID: 35449030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review of current status and challenges of vaccinating children against SARS-CoV-2.
    Zhang M; Zhang P; Liang Y; Du B; Li L; Yu Z; Wang H; Wang Q; Zhang X; Zhang W
    J Infect Public Health; 2022 Nov; 15(11):1212-1224. PubMed ID: 36257126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 Vaccination in Pregnancy and Lactation: Current Research and Gaps in Understanding.
    Shook LL; Fallah PN; Silberman JN; Edlow AG
    Front Cell Infect Microbiol; 2021; 11():735394. PubMed ID: 34604115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of Covid-19 mRNA vaccine on serum anti-Müllerian hormone levels.
    Mohr-Sasson A; Haas J; Abuhasira S; Sivan M; Doitch Amdurski H; Dadon T; Blumenfeld S; Derazne E; Hemi R; Orvieto R; Afek A; Rabinovici J
    Hum Reprod; 2022 Mar; 37(3):534-541. PubMed ID: 34935913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review of the safety, immunogenicity, and effectiveness of COVID-19 vaccines in pregnant and lactating individuals and their infants.
    Fu W; Sivajohan B; McClymont E; Albert A; Elwood C; Ogilvie G; Money D
    Int J Gynaecol Obstet; 2022 Mar; 156(3):406-417. PubMed ID: 34735722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and protective capability of an inactivated SARS-CoV-2 vaccine on pregnancy, lactation and the growth of offspring in hACE2 mice.
    Lin K; Liu M; Bao L; Lv Q; Zhu H; Li D; Xu Y; Xiang Z; Liu J; Liang X; Han Y; Cong Z; Liu R; Deng R; Wang S; Guo Z; Sun L; Wei Q; Qiao H; Wang S; Pan S; Gao H; Qin C
    Vaccine; 2022 Jul; 40(32):4609-4616. PubMed ID: 35738970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena.
    Chavda VP; Bezbaruah R; Athalye M; Parikh PK; Chhipa AS; Patel S; Apostolopoulos V
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of SARS-CoV-2-Specific IgA in the Human Milk of COVID-19 Vaccinated Lactating Health Care Workers.
    Valcarce V; Stafford LS; Neu J; Cacho N; Parker L; Mueller M; Burchfield DJ; Li N; Larkin J
    Breastfeed Med; 2021 Dec; 16(12):1004-1009. PubMed ID: 34427487
    [No Abstract]   [Full Text] [Related]  

  • 31. A Multicenter Cohort Study on the Adverse Effects Evaluation After Messenger RNA COVID-19 Vaccination Among Pregnant Healthcare Employees in Penang General Hospitals.
    Arulappen AL; Danial M; Shanmugam G; Cheng JT; Dulasi M; Chow TS
    Front Public Health; 2022; 10():876966. PubMed ID: 35677772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge, attitude, perceptions, and concerns of pregnant and lactating women regarding COVID-19 vaccination: A cross-sectional survey of 313 participants from a tertiary care centre of North India.
    Kumari A; Mahey R; Kachhawa G; Kumari R; Bhatla N
    Diabetes Metab Syndr; 2022 Mar; 16(3):102449. PubMed ID: 35279009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 disease and vaccination in pregnant and lactating women.
    Safadi MAP; Spinardi J; Swerdlow D; Srivastava A
    Am J Reprod Immunol; 2022 Jul; 88(1):e13550. PubMed ID: 35452552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing initial COVID-19 vaccine attitudes among pregnancy-capable healthcare workers.
    Perez MJ; Paul R; Raghuraman N; Carter EB; Odibo AO; Kelly JC; Foeller ME
    Am J Obstet Gynecol MFM; 2022 Mar; 4(2):100557. PubMed ID: 34952227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
    Poh XY; Lee IR; Lim C; Teo J; Rao S; Chia PY; Ong SWX; Lee TH; Lin RJH; Ng LFP; Ren EC; Lin RTP; Wang LF; Renia L; Lye DC; Young BE
    Trials; 2022 Jun; 23(1):498. PubMed ID: 35710572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.